Movement Alert|Semtech Rises 5.1% in Regular Trading, Q2 Earnings Beat and Data Center Momentum Fuel Continued Upside

Market Focus
Sep 08

On September 8, Semtech rose 5.1% in regular trading, trading at $155.16 per share, with turnover of approximately $77.49 million, as the market continued to price in the company's strong fiscal Q2 results and robust data center growth trajectory.

Semtech reported fiscal Q2 adjusted EPS of $0.71, beating the consensus estimate of $0.57 by roughly 25%, while revenue of $341.9 million topped the $328.6 million estimate. Fiscal Q3 revenue guidance of $405 million to $415 million significantly exceeded UBS's prior estimate of $376 million, with gross margin expectations running 230 basis points ahead of forecasts. Data center revenue surged 91% year-over-year in Q2, with Q3 projected to grow another 45% sequentially and 160% year-over-year. UBS maintained a Buy rating and raised its price target to $230 from $225, forecasting data center revenue could reach a $200 million quarterly run-rate by fiscal Q1 2028.

Additionally, the company's agreement to divest its cellular module business to Compal Electronics for $62 million is expected to improve gross margins by approximately 500 basis points, sharpening the company's focus on high-growth data center and IoT connectivity markets driven by AI infrastructure demand.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10